By Nishant Gupta, Associate Director, BioContinuum™ Platform
Interest in next generation processing enabled by digital technologies is driven by the need to accelerate the speed by which new medicines reach patients, to improve drug quality, to increase flexibility of manufacturing, and to reduce costs. This evolution is taking place in a bioprocessing landscape that has historically relied on multiple, disparate systems for data management and storage that don’t communicate effectively. Given the importance of data management and analytics, regulatory agencies are emphasizing the need for bioprocess monitoring, control, and detection of unplanned deviations, adding further motivation for change.
We developed the Bio4C Software™ Suite to help customers take a major step forward in the digital maturity continuum while remaining aligned with regulatory requirements. The suite includes individual, but seamlessly compatible software products to control, monitor and analyze equipment, processes, results, and data in near real time. The suite is based on 4Cs: Control, Connect, Collect and Collaborate and allows for data-driven decisions at both the process and plant levels.
This whitepaper highlights Bio4C ProcessPad™ Software, which is a part of the “Connect” platform for managing and analyzing complex process information for a deeper understanding of biopharma process. Several use cases demonstrating key benefits of Bio4C ProcessPad™ Software are provided.